Trabecular bone loss in collagen antibody-induced arthritis

[1]  E. Perilli,et al.  Quantifying Not Only Bone Loss, but Also Soft Tissue Swelling, in a Murine Inflammatory Arthritis Model Using Micro-Computed Tomography , 2015, Scandinavian journal of immunology.

[2]  C. Ohlsson,et al.  Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density , 2014, The Journal of endocrinology.

[3]  M. Robinson,et al.  Effect of sclerostin-neutralising antibody on periarticular and systemic bone in a murine model of rheumatoid arthritis: a microCT study , 2013, Arthritis Research & Therapy.

[4]  Y. Okayama,et al.  Fc receptor beta chain deficiency exacerbates murine arthritis in the anti-type II collagen antibody-induced experimental model , 2013, Modern rheumatology.

[5]  C. Terao,et al.  Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of Arthritis , 2013, PloS one.

[6]  H. Takayanagi,et al.  Osteoclasts in arthritis and Th17 cell development. , 2011, International immunopharmacology.

[7]  Kutty Selva Nandakumar,et al.  Effects of oestradiol and raloxifene on the induction and effector phases of experimental postmenopausal arthritis and secondary osteoporosis , 2011, Clinical and experimental immunology.

[8]  J. Dennis,et al.  Efficient osteoclast differentiation requires local complement activation. , 2010, Blood.

[9]  Ashley M. Miller,et al.  Mast cells express IL-17A in rheumatoid arthritis synovium. , 2010, Journal of immunology.

[10]  W. Arend,et al.  Pathogenic Complement Activation in Collagen Antibody- Induced Arthritis in Mice Requires Amplification by the Alternative Pathway1 , 2007, The Journal of Immunology.

[11]  A. Koch.  The pathogenesis of rheumatoid arthritis. , 2007, American journal of orthopedics.

[12]  Kutty Selva Nandakumar,et al.  Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis , 2007, Arthritis research & therapy.

[13]  Smith,et al.  Epidemiologic Aspects of Rheumatoid Arthritis , 2006 .

[14]  C. Ohlsson,et al.  Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation , 2005, Arthritis research & therapy.

[15]  A. Corrado,et al.  TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis , 2004 .

[16]  Kutty Selva Nandakumar,et al.  Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells , 2004, Arthritis research & therapy.

[17]  A. Corrado,et al.  TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. , 2004, Bone.

[18]  Kutty Selva Nandakumar,et al.  Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. , 2003, The American journal of pathology.

[19]  D. Mellström,et al.  Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis , 2003, Annals of the rheumatic diseases.

[20]  H. Fleisch.  Bisphosphonates in Bone Disease: From the Laboratory to the Patient , 2000 .

[21]  T. Martin,et al.  Tumor Necrosis Factor (cid:97) Stimulates Osteoclast Differentiation by a Mechanism Independent of the ODF/RANKL–RANK Interaction , 2022 .

[22]  T. Martin,et al.  IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. , 1999, The Journal of clinical investigation.

[23]  M. Rowley,et al.  Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. , 1996, Arthritis and rheumatism.

[24]  K. Morgan,et al.  Antibodies to type II collagen in early rheumatoid arthritis. , 1993, British journal of rheumatology.

[25]  A. Kang,et al.  Induction of arthritis with monoclonal antibodies to collagen. , 1992, Journal of immunology.

[26]  K. Metze.  Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours. , 1992, Virchows Archiv. A, Pathological anatomy and histopathology.

[27]  G. Verbruggen,et al.  Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. , 1990, The Journal of rheumatology.

[28]  W. Nichols.  LPS stimulation of complement (C3) synthesis by a human monocyte cell line. , 1984, Complement.